Adaptive immunity does not strongly suppress spontaneous tumors in a sleeping beauty model of cancer

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 4393-4399

  Rogers, Laura M ^a   Olivier, Alicia K ^a   Meyerholz, David K ^a   Dupuy, Adam J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ANGIOSARCOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FLOW CYTOMETRY; GASTROINTESTINAL TUMOR; GENE; IMMUNE DEFICIENCY; LATENT PERIOD; LEUKEMIA; MOUSE; MUTAGENESIS; MUTATION; NEOPLASM; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN TUMOR; TRANSPOSON; UBA1 GENE; WILD TYPE;

ADAPTIVE IMMUNITY; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; LEUKEMIA; MELANOMA, EXPERIMENTAL; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MONITORING, IMMUNOLOGIC; MUTAGENESIS; TRANSPOSASES; TUMOR ESCAPE;

EID: 84875978347     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203227     Document Type: Article

References (34)

1. Hanahan, D., and R. A. Weinberg. 2011. Hallmarks of cancer: the next generation. Cell 144: 646-674.
2. Jensen, P., S. Hansen, B. Møller, T. Leivestad, P. Pfeffer, O. Geiran, P. Fauchald, and S. Simonsen. 1999. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J. Am. Acad. Dermatol. 40: 177-186.
3. Mehrany, K., R. H. Weenig, K. K. Lee, M. R. Pittelkow, and C. C. Otley. 2005. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J. Am. Acad. Dermatol. 53: 1067-1071.
4. Wilkins, K., R. Turner, J. C. Dolev, P. E. LeBoit, T. G. Berger, and T. A. Maurer. 2006. Cutaneous malignancy and human immunodeficiency virus disease. J. Am. Acad. Dermatol. 54: 189-206.
5. Perrett, C. M., C. A. Harwood, J. M. McGregor, and P. Karran. 2009. Carcinogenic mechanisms related to immunosuppressive therapy. Cancer Treat. Res. 146: 123-132.
6. Swann, J. B., and M. J. Smyth. 2007. Immune surveillance of tumors. J. Clin. Invest. 117: 1137-1146.
7. Koebel, C. M., W. Vermi, J. B. Swann, N. Zerafa, S. J. Rodig, L. J. Old, M. J. Smyth, and R. D. Schreiber. 2007. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450: 903-907.
8. Dupuy, A. J., L. M. Rogers, J. Kim, K. Nannapaneni, T. K. Starr, P. Liu, D. A. Largaespada, T. E. Scheetz, N. A. Jenkins, and N. G. Copeland. 2009. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res. 69: 8150-8156.
9. Brett, B. T., K. E. Berquam-Vrieze, K. Nannapaneni, J. Huang, T. E. Scheetz, and A. J. Dupuy. 2011. Novel molecular and computational methods improve the accuracy of insertion site analysis in Sleeping Beauty-induced tumors. PLoS ONE 6: e24668.
10. Shinkai, Y., G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
11. Berquam-Vrieze, K. E., K. Nannapaneni, B. T. Brett, L. Holmfeldt, J. Ma, O. Zagorodna, N. A. Jenkins, N. G. Copeland, D. K. Meyerholz, C. M. Knudson, et al. 2011. Cell of origin strongly influences genetic selection in a mouse model of T-ALL. Blood 118: 4646-4656.
12. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔC(T) method. Methods 25: 402-408.
13. Fidler, I. J. 1975. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35: 218-224.
14. Waldhauer, I., and A. Steinle. 2008. NK cells and cancer immunosurveillance. Oncogene 27: 5932-5943.
15. Shankaran, V., H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson, L. J. Old, and R. D. Schreiber. 2001. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410: 1107-1111.
16. Collier, L. S., D. J. Adams, C. S. Hackett, L. E. Bendzick, K. Akagi, M. N. Davies, M. D. Diers, F. J. Rodriguez, A. M. Bender, C. Tieu, et al. 2009. Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res. 69: 8429-8437.
17. van der Weyden, L., G. Giotopoulos, A. G. Rust, L. S. Matheson, F. W. van Delft, J. Kong, A. E. Corcoran, M. F. Greaves, C. G. Mullighan, B. J. Huntly, and D. J. Adams. 2011. Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice. Blood 118: 1041-1051.
18. Matsushita, H., M. D. Vesely, D. C. Koboldt, C. G. Rickert, R. Uppaluri, V. J. Magrini, C. D. Arthur, J. M. White, Y. S. Chen, L. K. Shea, et al. 2012. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482: 400-404.
19. DuPage, M., C. Mazumdar, L. M. Schmidt, A. F. Cheung, and T. Jacks. 2012. Expression of tumour-specific antigens underlies cancer immunoediting. Nature 482: 405-409.
20. Hodge, J. W., J. W. Greiner, K. Y. Tsang, H. Sabzevari, C. Kudo-Saito, D. W. Grosenbach, J. L. Gulley, P. M. Arlen, J. L. Marshall, D. Panicali, and J. Schlom. 2006. Costimulatory molecules as adjuvants for immunotherapy. Front. Biosci. 11: 788-803.
21. Reuschenbach, M., M. von Knebel Doeberitz, and N. Wentzensen. 2009. A systematic review of humoral immune responses against tumor antigens. Cancer Immunol. Immunother. 58: 1535-1544.
22. Coulie, P. G., V. Karanikas, C. Lurquin, D. Colau, T. Connerotte, T. Hanagiri, A. Van Pel, S. Lucas, D. Godelaine, C. Lonchay, et al. 2002. Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen. Immunol. Rev. 188: 33-42.
23. Rosenberg, S. A., J. C. Yang, D. J. Schwartzentruber, P. Hwu, F. M. Marincola, S. L. Topalian, N. P. Restifo, M. E. Dudley, S. L. Schwarz, P. J. Spiess, et al. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4: 321-327.
24. Lennerz, V., M. Fatho, C. Gentilini, R. A. Frye, A. Lifke, D. Ferel, C. Wölfel, C. Huber, and T. Wölfel. 2005. The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc. Natl. Acad. Sci. USA 102: 16013-16018.
25. Shimokado, K., H. Watanabe, M. Sumii, K. Miyagawa, K. Kamiya, K. Dohi, and O. Niwa. 1998. p53 gene mutation and loss of heterozygosity of chromosome 11 in methylcholanthrene-induced mouse sarcomas. Jpn. J. Cancer Res. 89: 269-277.
26. Brown, K., A. Buchmann, and A. Balmain. 1990. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl. Acad. Sci. USA 87: 538-542.
27. Moudry, P., C. Lukas, L. Macurek, H. Hanzlikova, Z. Hodny, J. Lukas, and J. Bartek. 2012. Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage. Cell Cycle 11: 1573-1582.
28. Xu, G. W., M. Ali, T. E. Wood, D. Wong, N. Maclean, X. Wang, M. Gronda, M. Skrtic, X. Li, R. Hurren, et al. 2010. The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma. Blood 115: 2251-2259.
29. Shacter, E., and S. A. Weitzman. 2002. Chronic inflammation and cancer. Oncology (Williston Park) 16: 217-226, 229.
30. Seliger, B. 2005. Strategies of tumor immune evasion. BioDrugs 19: 347-354.
31. Qin, Z., H. J. Kim, J. Hemme, and T. Blankenstein. 2002. Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction. J. Exp. Med. 195: 1479-1490.
32. Masini, C., P. G. Fuchs, F. Gabrielli, S. Stark, F. Sera, M. Ploner, C. F. Melchi, G. Primavera, G. Pirchio, O. Picconi, et al. 2003. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch. Dermatol. 139: 890-894.
33. Feldmeyer, L., M. Keller, G. Niklaus, D. Hohl, S. Werner, and H. D. Beer. 2007. The inflammasome mediates UVB-induced activation and secretion of interleukin-1β by keratinocytes. Curr. Biol. 17: 1140-1145.
34. Boccardo, E., A. P. Lepique, and L. L. Villa. 2010. The role of inflammation in HPV carcinogenesis. Carcinogenesis 31: 1905-1912.